- Solid Biosciences Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Solid Biosciences Inc at Citi BioPharma Conference TranscriptSep 07, 2023
- Solid Biosciences Inc at Barclays Virtual Gene Editing & Therapy Summit TranscriptMay 24, 2023
- Solid Biosciences Inc at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- Solid Biosciences Inc at Chardan Genetic Medicines & Cell Therapy Manufacturing Summit (Virtual) TranscriptApr 24, 2023
- Solid Biosciences Inc at Needham Healthcare Conference (Virtual) TranscriptApr 20, 2023
- Solid Biosciences Inc at BMO Capital Markets BioPharma Spotlight Series: Genetic Medicine Delivery (Virtual) TranscriptMar 28, 2023
- Solid Biosciences Inc at Barclays Global Healthcare Conference TranscriptMar 14, 2023
- Solid Biosciences Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- Solid Biosciences Inc To Acquire Aavantibio Inc Call TranscriptSep 30, 2022
- Q1 2022 Solid Biosciences Inc Earnings Call TranscriptApr 27, 2022$9.65 (-16.98%)Earnings
- Solid Biosciences Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2022
- Solid Biosciences Inc at Jefferies Gene Therapy/Editing Summit (Virtual) TranscriptOct 28, 2021
- Solid Biosciences Inc at Chardan Genetic Medicines Conference (Virtual) TranscriptOct 05, 2021
- Q1 2021 Solid Biosciences Inc Earnings Call TranscriptMay 14, 2021$52.35 (-21.40%)Earnings
- Pfizer Inc, Avidity Biosciences, Sarepta Therapeutics, Solid Biosciences, and Ultragenyx Pharmaceutical at Guggenheim Partners Healthcare Talks: Genomic Medicines & Rare Disease (Virtual) TranscriptApr 01, 2021
- Solid Biosciences Inc. - Special Call TranscriptMar 15, 2021
- Solid Biosciences Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 11, 2021
- Solid Biosciences Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Q3 2020 Solid Biosciences Inc Earnings Call TranscriptNov 05, 2020$48.6Earnings
- Solid Biosciences Inc Annual Shareholders Meeting TranscriptJun 16, 2020
- Solid Biosciences Inc. - Special Call TranscriptDec 18, 2019
- Solid Biosciences Inc. - Special Call TranscriptNov 12, 2019
Solid Biosciences Inc at Chardan Genetic Medicines & Cell Therapy Manufacturing Summit (Virtual) Transcript
Good afternoon. It's now my pleasure to introduce Kevin Tan, CFO; Paul Herzich, CTO; and Brian Collins, SVP at Solid. Thank you all for joining us today. The format for this session, roughly a 25 minutes fireside chat. (Operator Instructions) And to start off, perhaps you could give us an overview of Solid' CMC capabilities and how they fit into the company's overall strategy and the overall approach going forward?
Absolutely. Thank you so much for having us, and we're so please be participating in the Chardan conference and the manufacturing summit.
I think I'll start off first by just reiterating that there may be forward-looking statements made and we may need to disclaim any obligation update that in the future, even if they do change.
I think it's important [suite] to orient everyone around Solid as a new company. In December 2, 2022, we completed our merger with Avanti Biosciences and combined both companies' pipelines. People here might remember Solid
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)